ABVC BioPharma Inc (ABVC)
1.11
+0.05
(+4.72%)
USD |
NASDAQ |
May 08, 16:00
1.11
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Revenue (Quarterly): 0.0022M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0022M |
| September 30, 2023 | 0.0159M |
| June 30, 2023 | 0.0061M |
| March 31, 2023 | 0.1283M |
| December 31, 2022 | 0.589M |
| September 30, 2022 | 0.0423M |
| June 30, 2022 | 0.3129M |
| March 31, 2022 | 0.0257M |
| December 31, 2021 | -0.0378M |
| September 30, 2021 | 0.099M |
| June 30, 2021 | 0.0314M |
| March 31, 2021 | 0.2631M |
| December 31, 2020 | 0.0622M |
| September 30, 2020 | 0.1156M |
| June 30, 2020 | 0.2265M |
| March 31, 2020 | 0.0788M |
| December 31, 2019 | 0.10M |
| September 30, 2019 | 0.1977M |
| June 30, 2019 | 0.1918M |
| March 31, 2019 | 0.2122M |
| December 31, 2018 | -0.004M |
| September 30, 2018 | 0.0007M |
| June 30, 2018 | 0.0032M |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 0.0011M |
| June 30, 2015 | |
| March 31, 2015 | 0.0023M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | 0.0008M |
| December 31, 2012 | 0.007M |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | 0.0037M |
| December 31, 2011 | 0.002M |
| September 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.0378M
Minimum
Dec 2021
0.589M
Maximum
Dec 2022
0.129M
Average
0.099M
Median
Sep 2021
Revenue (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -- |
| Sutro Biopharma Inc | 113.72M |
| Reviva Pharmaceuticals Holdings Inc | -- |
| Flora Growth Corp | 17.98M |
| Journey Medical Corp | 15.26M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.111M |
| Total Expenses (Quarterly) | 1.964M |
| EPS Diluted (Quarterly) | -0.3931 |
| Enterprise Value | 12.79M |
| Gross Profit Margin (Quarterly) | -6.33K% |
| Profit Margin (Quarterly) | -143.7K% |
| Earnings Yield | -224.6% |
| Normalized Earnings Yield | -222.03 |